1
|
Nordanstig J, Behrendt CA, Bradbury AW, de Borst GJ, Fgr F, Golledge J, Gottsater A, Hinchliffe RJ, Nikol S, Norgren L. Peripheral arterial disease (PAD) - A challenging manifestation of atherosclerosis. Prev Med 2023; 171:107489. [PMID: 37031910 DOI: 10.1016/j.ypmed.2023.107489] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/30/2022] [Revised: 03/13/2023] [Accepted: 03/17/2023] [Indexed: 04/11/2023]
Abstract
The diagnosis of peripheral arterial disease (PAD) is not always evident as symptoms and signs may show great variation. As all grades of PAD are linked to both an increased risk for cardiovascular complications and adverse limb events, awareness of the condition and knowledge about diagnostic measures, prevention and treatment is crucial. This article presents in a condensed form information on PAD and its management.
Collapse
Affiliation(s)
- J Nordanstig
- Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden; Department of Vascular Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden
| | - C A Behrendt
- Department of Vascular and Endovascular Surgery, Asklepios Clinic Wandsbek, Asklepios Medical School, Hamburg, Germany
| | - A W Bradbury
- Department of Vascular Surgery, University of Birmingham, Birmingham, United Kingdom
| | - G J de Borst
- Department of Vascular Surgery, University Medical Centre Utrecht, Utrecht, the Netherlands
| | - Fowkes Fgr
- Centre for Global Health Research, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, United Kingdom
| | - J Golledge
- Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry, James Cook University and Department of Vascular and Endovascular Surgery, Townsville University Hospital, Townsville, QLD, Australia
| | - A Gottsater
- Department of Internal Medicine, Skane University Hospital, University of Lund, Malmo, Sweden
| | - R J Hinchliffe
- Department of Vascular Surgery, University of Bristol, Bristol, United Kingdom
| | - S Nikol
- Department of Angiology, Asklepios Klinik St Georg, Hamburg, Germany
| | - L Norgren
- Department of Surgery, Faculty of Medicine and Health, Örebro University, Sweden.
| |
Collapse
|
2
|
Jansson K, Strand I, Redler B, Magnuson A, Ungerstedt U, Norgren L. Results of intraperitoneal microdialysis depend on the location of the catheter. Scandinavian Journal of Clinical and Laboratory Investigation 2020; 64:63-70. [PMID: 15025430 DOI: 10.1080/00365510410004100] [Citation(s) in RCA: 35] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
BACKGROUND AND OBJECTIVE Intraperitoneal microdialysis was recently described as a method for early detection of visceral ischemia. The method seems safe and accurate. The intra-abdominal catheter used may imply variations in results depending on the location of the catheter. The aim of the study was to investigate possible differences in metabolic parameters obtained depending on various locations of the intra-abdominal catheter, compared with using the subcutaneous reference catheter. METHOD After right-sided hemicolectomy in 12 patients, three catheters were placed and fixed intraperitoneally: one at the anastomosis, one in the omentum and one embedded between the small intestinal loops. A subcutaneous catheter placed in the pectoral region was used as reference. Analyses of lactate/pyruvate ratio and glucose and glycerol levels were done during a period of 45 hours postoperatively. RESULTS Lactate/pyruvate ratio decreased numerically at all three intraperitoneal locations during the study while the subcutaneous lactate/pyruvate ratio increased slightly. Significant differences between intraperitoneal and subcutaneous locations were found as well as differences between the three intraperitoneal locations. Highest values of the lactate/pyruvate ratio were found at the anastomosis, while the widest range was found at the small intestine. Subcutaneous glucose levels were lower while glycerol levels were higher compared with intraperitoneal values. CONCLUSIONS In evaluating postoperative metabolism, intraperitoneal microdialysis is influenced by the location of the microdialysis catheter. The same pattern is, however, recorded over time. The juxta-anastomotic region and the small intestinal loop area seem to be the most reasonable locations for measurements.
Collapse
Affiliation(s)
- K Jansson
- Department of Surgery, Orebro University Hospital, Orebro, Sweden.
| | | | | | | | | | | |
Collapse
|
3
|
Hiatt W, Hopley CW, Kavanagh S, Patel MR, Baumgartner I, Berger JS, Blomster JI, Fowkes FGR, Jones WS, Katona BG, Mahaffey KW, Norgren L. P935Effect of hypertension and systolic blood pressure on cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: the EUCLID trial. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz747.0529] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Hypertension is a risk factor for major adverse cardiac events (MACE) in patients with symptomatic peripheral artery disease (PAD).
Purpose
The effects of a history of hypertension and baseline systolic blood pressure (SBP) on MACE and major adverse limb events (MALE), including acute limb ischemia and major amputation, were evaluated in the Examining Use of tiCagreLor In paD (EUCLID) trial.
Methods
EUCLID randomized 13,885 patients with PAD and found no benefit of ticagrelor compared with clopidogrel on risk of MACE or MALE. The median duration of follow up was approximately 30 months. This post hoc, subgroup analysis evaluated the effects of hypertension history at baseline on the hazard for MACE and MALE. An adjusted restricted cubic spline regression analysis evaluated the association of SBP with MACE and MALE.
Results
A clinical history of hypertension was present in 10,857 (78%) patients at baseline and these patients were more likely to be older, female, white or African American, and reside in North America compared with the 3026 without hypertension. Hypertension was associated with a higher prevalence of concomitant cardiovascular diseases, polyvascular disease, diabetes, and prior coronary interventions. MACE occurred at a rate of 4.63 events/100 pt-yrs in participants with hypertension and 3.64 events/100 pt-yrs in participants without hypertension, (adjusted hazard ratio [aHR] 0.94, 95% CI 0.82–1.08; p=0.38). MALE occurred at a rate of 1.11 events/100 pt-yrs in those with hypertension and 1.38 events/100 pt-yrs in those without hypertension (p=0.054) (aHR 0.93 (95% CI 0.73, 1.18) p=0.55. The adjusted spline model for MACE and SBP demonstrated a significantly non-linear relationship with a HR 1.08 (95% CI 1.01, 1.15), p=0.0275 for every 10-unit decrease <135 mmHg SBP and HR 1.11 (1.06, 1.16), p<0.0001 for every 10-unit increase >135 mmHg (figure). There was no association between baseline SBP and MALE events.
Conclusions
A history of hypertension was not associated with a higher adjusted hazard for MACE or MALE in participants with PAD. In contrast, SBP at baseline was associated with increased risk of MACE at values both above and below 135 mmHg.
Acknowledgement/Funding
EUCLID was sponsored by AstraZeneca
Collapse
Affiliation(s)
- W Hiatt
- CPC Clinical Research, University of Colorado School of Medicine, Aurora, United States of America
| | - C W Hopley
- Geisel School of Medicine, Dartmouth College, Department of Medicine, Section of Nephrology and Hypertension, Hanover, United States of America
| | - S Kavanagh
- CPC Clinical Research, Aurora, United States of America
| | - M R Patel
- Duke Clinical Research Institute, Duke University School of Medicine, Durham, United States of America
| | - I Baumgartner
- Swiss Cardiovascular Center, University of Bern, Bern, Switzerland
| | - J S Berger
- New York University School of Medicine, Departments of Medicine and Surgery, New York, United States of America
| | | | - F G R Fowkes
- University of Edinburgh, Usher Institute of Population Health Sciences and Informatics, Edinburgh, United Kingdom
| | - W S Jones
- Duke Clinical Research Institute, Duke University School of Medicine, Durham, United States of America
| | - B G Katona
- AstraZeneca Gaithersburg, Gaithersburg, United States of America
| | - K W Mahaffey
- Stanford Center for Clinical Research, Stanford University School of Medicine, Stanford, United States of America
| | - L Norgren
- Orebro University, Faculty of Medicine and Health, Orebro, Sweden
| |
Collapse
|
4
|
Hopley CW, Kavanagh S, Patel M, Baumgartner I, Berger JS, Blomster JI, Fowkes FGR, Jones WS, Katona BG, Mahaffey KW, Norgren L, Held P, Rockhold FW, Hiatt WR. 4065Moderate to severe renal insufficiency and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: the EUCLID trial. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.4065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- C W Hopley
- University of Colorado School of Medicine, CPC Clinical Research, Aurora, United States of America
| | - S Kavanagh
- CPC Clinical Research, Aurora, United States of America
| | - M Patel
- Duke University Medical Center, Duke Clinical Research Institute, Durham, United States of America
| | - I Baumgartner
- Swiss Cardiovascular Centre, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - J S Berger
- New York University School of Medicine, New York, United States of America
| | - J I Blomster
- Turku University Hospital, Heart Centre, Turku, Finland
| | - F G R Fowkes
- Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom
| | - W S Jones
- Duke University Medical Center, Duke Clinical Research Institute, Durham, United States of America
| | - B G Katona
- AstraZeneca Gaithersburg, Gaithersburg, United States of America
| | - K W Mahaffey
- Stanford Center for Clinical Research, Stanford University School of Medicine, Stanford, United States of America
| | - L Norgren
- Faculty of Medicine and Health, Orebro University, Orebro, Sweden
| | - P Held
- AstraZeneca Gothenburg, Molndal, Sweden
| | - F W Rockhold
- Duke Clinical Research Institute, Durham, United States of America
| | - W R Hiatt
- CPC Clinical Research, University of Colorado School of Medicine, Aurora, United States of America
| | | |
Collapse
|
5
|
Swartbol P, Pärsson H, Nässberger L, Norgren L. Metabolic Response of Blood Cells to Synthetic Graft-Materials with Special Reference to a Fluoromer Passivated Dacron® Graft. An in Vitro Study Using Microcalorimetry. Int J Artif Organs 2018. [DOI: 10.1177/039139889501800705] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Microcalorimetry was used to study in vitro the metabolic response from human platelets and leukocytes when incubated with three different synthetic graft-materials. The graft to be studied primarily was Fluoromer Passivated Dacron (FPD) which was compared with ePTFE and with a knitted Teflon graft. A rapid increase in the metabolic activity of platelets was observed, followed by a steady-state for more than one hour, while the platelet metabolism did not differ among the various graft-materials. Leukocytes incubated with FPD showed a high initial metabolism, with a peak after about 15 minutes. After 60 minutes the metabolic response had reached control values. ePTFE and Teflon grafts differed significantly from FPD, without causing any peak metabolic activity. It may be concluded that FPD and ePTFE grafts, as evaluated in vitro, activate platelets to the same extent, while FPD causes a more extensive leukocyte activation. Whether these findings can be interpreted as differences in thrombogenicity and inflammatory responses has not been proven, but seems probable. This in vitro method should make it possible to further study human responses to synthetic materials a method possibly more reliable than animal experiments.
Collapse
Affiliation(s)
- P. Swartbol
- Departments of Surgery and Clinical Immunology, Lund University, Lund - Sweden
| | - H. Pärsson
- Departments of Surgery and Clinical Immunology, Lund University, Lund - Sweden
| | - L. Nässberger
- Departments of Surgery and Clinical Immunology, Lund University, Lund - Sweden
| | - L. Norgren
- Departments of Surgery and Clinical Immunology, Lund University, Lund - Sweden
| |
Collapse
|
6
|
Norgren L, Patel M, Hiatt W, Wojdyla D, Fowkes F, Baumgartner I, Mahaffey K, Berger J, Jones W, Katona B, Held P, Blomster J, Rockhold F, Björck M. Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial. J Vasc Surg 2018. [DOI: 10.1016/j.jvs.2017.12.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
7
|
Berger J, Heizer G, Baumgartner I, Fowkes F, Held P, Katona B, Norgren L, Jones W, Lopes R, Abramson B, Millegard M, Blomster J, Hiatt W, Patel M, Mahaffey K. 2259Ticagrelor in patients wtih symptomatic peripheral artery disease and prior coronary artery disease. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx502.2259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- J. Berger
- New York University School of Medicine, Departments of Medicine and Surgery, New York, United States of America
| | - G. Heizer
- Duke Clinical Research Institute, Duke University School of Medicine, Durham, United States of America
| | - I. Baumgartner
- Bern University Hospital, University of Bern, Bern, Switzerland
| | | | - P. Held
- AstraZeneca Gothenburg, Molndal, Sweden
| | - B.G. Katona
- AstraZeneca Gaithersburg, Gaithersburg, United States of America
| | | | - W.S. Jones
- Duke Clinical Research Institute, Duke University School of Medicine, Durham, United States of America
| | - R.D. Lopes
- Duke Clinical Research Institute, Duke University School of Medicine, Durham, United States of America
| | | | | | | | - W.R. Hiatt
- University of Colorado School of Medicine and CPC Clinical Research, Aurora, United States of America
| | - M.R. Patel
- Duke Clinical Research Institute, Duke University School of Medicine, Durham, United States of America
| | - K.W. Mahaffey
- Stanford University School of Medicine, Stanford, United States of America
| | | |
Collapse
|
8
|
Kolls B, Sapp S, Hiatt W, Norgren L, Berger J, Rockhold F, Katona B, Blomster J, Jones W, Patel M, Mahaffey K. P5198The occurrence of stroke and TIA in patients with peripheral artery disease and the effect of ticagrelor versus clopidogrel in EUCLID. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.p5198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- B. Kolls
- Duke University Medical Center, Durham, United States of America
| | - S. Sapp
- Duke University Medical Center, Duke Clinical Research Institute, Durham, United States of America
| | - W.R. Hiatt
- University of Colorado School of Medicine and CPC Clinical Research, Aurora, United States of America
| | | | - J.S. Berger
- New York University School of Medicine, New York, United States of America
| | - F.W. Rockhold
- Duke University Medical Center, Duke Clinical Research Institute, Durham, United States of America
| | - B.G. Katona
- AstraZeneca Gaithersburg, Gaithersburg, United States of America
| | | | - W.S. Jones
- Duke University Medical Center, Duke Clinical Research Institute, Durham, United States of America
| | - M.R. Patel
- Duke University Medical Center, Duke Clinical Research Institute, Durham, United States of America
| | - K.W. Mahaffey
- Stanford University School of Medicine, Stanford, United States of America
| | | |
Collapse
|
9
|
Abstract
This was a multinational, multicentre, double-blind Phase II study in Europe to evaluate the efficacy and safety of two dose regimens (200 mg bid and 200 mg tid) of sarpogrelate (MCI-9042, 5-HT2A receptor antagonist) compared to placebo in patients with stable, moderately severe intermittent claudication. Following a single-blind placebo run-in period of 6 weeks, 364 (309 male and 55 female) patients (59.2 ± 8.4 years, mean SD) were randomized to receive sarpogrelate 200 mg bid, 200 mg tid or placebo for 24 weeks with a follow-up of 8 weeks. The primary objective was the increase of absolute claudication distance (ACD) at the end of treatment (week 24) compared to placebo. Analysis of covariance (ANCOVA) was performed on the log-transformed percentage of baseline ACD: loge (ACD/baseline). A responder analysis (defined as a 50% improvement in ACD) was also performed. There was a marked training/placebo effect on the ACD which persisted up to 16 weeks. At 24 weeks the primary objective did not reach statistical significance (200 mg bid vs placebo, p = 0.225; 200 mg tid vs placebo, p = 0.580). In the responder analysis, 200 mg bid showed a statistically significant difference vs placebo ( p = 0.035). In the exploratory analysis with completers (patients completing all treadmill tests), there was a statistical difference in ACD/baseline change for 200 mg bid ( p = 0.035) and in the responder analysis for 200 mg tid ( p = 0.044) at 24 weeks compared to placebo. Both treatments showed a carry-over effect for ACD during the 8-week follow-up (weeks 28-32). The treatment was well tolerated and no clinically significant safety concerns were reported. In conclusion, the study results confirm that sarpogrelate is well tolerated and although the primary endpoint failed to reach statistical significance, the responder analysis showed an increased absolute walking distance, which makes a further trial warranted, including a larger population, and possibly also a longer treatment period.
Collapse
Affiliation(s)
- L Norgren
- Department of Surgery, University Hospital, Orebro, Sweden.
| | | | | | | | | |
Collapse
|
10
|
Danielsson P, Truedsson L, Eriksson KF, Norgren L. Inflammatory markers and IL-6 polymorphism in peripheral arterial disease with and without diabetes mellitus. Vasc Med 2016; 10:191-8. [PMID: 16235772 DOI: 10.1191/1358863x05vm617oa] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Peripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis, recognized as an inflammatory disease of the vessel wall, probably accelerated by diabetes mellitus (DM). Elevated interleukin (IL)-6 levels have been associated with increased cardiovascular morbidity and a common polymorphism has been identified in the promoter region of the IL-6 gene. The aim of this prospective study was to investigate inflammatory mediators in PAD patients (±DM) and to investigate a possible relationship to the IL-6 gene polymorphism. Five groups of patients (DM, intermittent claudication ±DM, critical limb ischemia (CLI) ±DM) and a control group of 20 individuals each were included. Hemoglobin, high sensitive C-reactive protein (hsCRP), creatinine, blood lipids, white blood cells (WBC); CD11b/CD18; vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1), sE-selectin, sP-selectin; IL-6, IL-8, tumour necrosis factor (TNF)α, sTNFα-R1 and sTNFα-R2 were analysed. The IL-6 gene polymorphism was determined in all groups and also compared with 200 healthy controls from a larger study of blood donors. In a multiple regression analysis, adjusted for gender, smoking and age, the effect of CLI was significantly ( p < 0.05) associated with elevated levels of the WBC count, hsCRP, proinflammatory cytokines (IL-6, TNFα-R1-2) and endothelial (sICAM, sVCAM) and WBC (CD11b gran) markers. The effect of less advanced PAD (intermittent claudication) was related to an increased concentration of sVCAM-1 and the number of monocytes and granulocytes. DM or leg ulcers were not significantly related to any of the markers. No significant difference in frequency of the various IL-6 genotypes was found between the groups or when compared with the group of 200 blood donors ( p > 0.3). Activation of cytokines, endothelial cells and WBC was related to the Fontaine stage of PAD but not to the presence of DM or ulcers. No association was found between the polymorphism in the IL-6 promoter region and PAD.
Collapse
Affiliation(s)
- P Danielsson
- Department of Vascular Diseases, University Hospital MAS, Malmö, Sweden.
| | | | | | | |
Collapse
|
11
|
Abstract
Two contrast media, iodixanol (Visipaque, Nycomed) 270 mg I/ml and iohexol (Omnipaque, Nycomed) 300 mg I/ml, were compared in femoral arteriography, in 147 patients. Both contrast media were diagnostically effective for use in femoral arteriography, without any significant difference. Pain was reported in connection with injection of iohexol by 36% of the patients, after injection of iodixanol none reported pain. Seventy-two percent of the patients in the iodixanol group reported a sensation of warmth in connection with contrast injection versus 90% in the iohexol group. The average intensity of the warmth was greater with iohexol than with iodixanol. Fourteen percent of patients in the iodixanol group and 1% in the iohexol group reported one or more subjective adverse events.
Collapse
Affiliation(s)
- Ö. Thorstensen
- Departments of Radiology, Huddinge Hospital, Karolinska Institute, Stockholm, University Hospital, Lund, and Södersjukhuset, Stockholm, and the Department of Surgery, University Hospital, Lund and Nycomed Imaging AS, Oslo, Norway
| | - U. Albrechtsson
- Departments of Radiology, Huddinge Hospital, Karolinska Institute, Stockholm, University Hospital, Lund, and Södersjukhuset, Stockholm, and the Department of Surgery, University Hospital, Lund and Nycomed Imaging AS, Oslo, Norway
| | - B. Calissendorff
- Departments of Radiology, Huddinge Hospital, Karolinska Institute, Stockholm, University Hospital, Lund, and Södersjukhuset, Stockholm, and the Department of Surgery, University Hospital, Lund and Nycomed Imaging AS, Oslo, Norway
| | - H. Lárusdóttir
- Departments of Radiology, Huddinge Hospital, Karolinska Institute, Stockholm, University Hospital, Lund, and Södersjukhuset, Stockholm, and the Department of Surgery, University Hospital, Lund and Nycomed Imaging AS, Oslo, Norway
| | - L. Norgren
- Departments of Radiology, Huddinge Hospital, Karolinska Institute, Stockholm, University Hospital, Lund, and Södersjukhuset, Stockholm, and the Department of Surgery, University Hospital, Lund and Nycomed Imaging AS, Oslo, Norway
| | - M. Tengvaw
- Departments of Radiology, Huddinge Hospital, Karolinska Institute, Stockholm, University Hospital, Lund, and Södersjukhuset, Stockholm, and the Department of Surgery, University Hospital, Lund and Nycomed Imaging AS, Oslo, Norway
| | - B. Bolstad
- Departments of Radiology, Huddinge Hospital, Karolinska Institute, Stockholm, University Hospital, Lund, and Södersjukhuset, Stockholm, and the Department of Surgery, University Hospital, Lund and Nycomed Imaging AS, Oslo, Norway
| | - P. Aspelin
- Departments of Radiology, Huddinge Hospital, Karolinska Institute, Stockholm, University Hospital, Lund, and Södersjukhuset, Stockholm, and the Department of Surgery, University Hospital, Lund and Nycomed Imaging AS, Oslo, Norway
| |
Collapse
|
12
|
Abstract
In 26 patients iodixanol, a new nonionic dimer, isotonic to blood in all concentrations, was used as contrast medium in aortofemoral angiography. Half of the patients received contrast medium in a concentration of 270 mg I/ml and the other half 320 mg I/ml. The aim of the trial was to evaluate the safety and tolerability of iodixanol and the radiographic efficacy of the two concentrations. The degree of discomfort, adverse events, changes in serum chemistry parameters, and diagnostic information were assessed. There were no changes or trends of clinical importance in serum chemistry parameters. The side effects were mild and consisted mostly of some sensation of warmth of short duration. No other adverse events were seen. The overall radiographic efficacy did not show any significant difference between the two concentrations. This indicates that iodixanol is safe and well tolerated when used in adult femoral angiography.
Collapse
Affiliation(s)
- U. Albrechtsson
- Departments of Diagnostic Radiology and Surgery, University Hospital, Lund, Sweden, and Nycomed AS, Oslo, Norway
| | - H. Lárusdóttir
- Departments of Diagnostic Radiology and Surgery, University Hospital, Lund, Sweden, and Nycomed AS, Oslo, Norway
| | - L. Norgren
- Departments of Diagnostic Radiology and Surgery, University Hospital, Lund, Sweden, and Nycomed AS, Oslo, Norway
| | - B. Lundby
- Departments of Diagnostic Radiology and Surgery, University Hospital, Lund, Sweden, and Nycomed AS, Oslo, Norway
| |
Collapse
|
13
|
Cronberg CN, Sjöberg S, Albrechtsson U, Leander P, Lindh M, Norgren L, Danielsson P, Sonesson B, Larsson EM. Peripheral arterial disease. Contrast-enhanced 3D MR angiography of the lower leg and foot compared with conventional angiography. Acta Radiol 2016. [DOI: 10.1258/rsmacta.44.1.59] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Purpose: To determine whether contrast-enhanced 3D MR angiography (CE MRA) could replace digital subtraction angiography (DSA) for the evaluation of atherosclerotic peripheral vascular disease of the lower leg and foot. Material and Methods: Thirty-five patients with symptoms of atherosclerotic disease of the leg were examined prospectively with CE MRA of the foot and the lower legs as well as with DSA from the aorta to the pedal arches. The MRA technique was focused on optimal imaging of the arteries of the foot. Results: The agreement between CE MRA and DSA for grading of stenosis was moderate to good (weighted κ-values 0.48–0.80). The sensitivity of CE MRA for detection of significant stenosis (≥ 50%) was 92% and the specificity was 64% with DSA as gold standard. Conclusion: CE MRA is a fairly accurate method for the demonstration of atherosclerotic disease below the knee including the pedal arches. It can replace DSA for the assessment of distal arteries in patients with impaired renal function. However, image quality and resolution still needs to be improved before CE MRA can become the method of choice in all patients.
Collapse
Affiliation(s)
- C. N. Cronberg
- Center for Medical Imaging and Physiology, University Hospital, Lund, Sweden
| | - S. Sjöberg
- Department of Diagnostic Radiology, University Hospital, Lund, Sweden
| | - U. Albrechtsson
- Center for Medical Imaging and Physiology, University Hospital, Lund, Sweden
| | - P. Leander
- Department of Diagnostic Radiology, University Hospital, Lund, Sweden
| | - M. Lindh
- Department of Diagnostic Radiology, University Hospital, Lund, Sweden
| | - L. Norgren
- Department of Vascular Surgery Malmö/Lund, University Hospital, Malmö, Sweden
| | - P. Danielsson
- Department of Vascular Surgery Malmö/Lund, University Hospital, Malmö, Sweden
| | - B. Sonesson
- Department of Vascular Surgery Malmö/Lund, University Hospital, Malmö, Sweden
| | - E.-M. Larsson
- Center for Medical Imaging and Physiology, University Hospital, Lund, Sweden
| |
Collapse
|
14
|
Abstract
Experience is reported on a simple, inexpensive video processor for angiographic control during operation. In 6 patients with graft complications instant operative corrections could be performed.
Collapse
|
15
|
Abstract
Twenty-five patients with clinical relapse after previous successful angioplasty of iliac or femoro-popliteal arteries were evaluated with repeat angiography. The angiographic patency was 80% despite the clinical symptoms. The discrepancy between the angiographic appearance and the clinical findings was explained by the progress of the general arteriosclerotic vascular disease. Such progression is more important regarding late prognosis than the result of the angioplasty per se.
Collapse
|
16
|
Abstract
Purpose: To review the findings of two studies investigating the apparent differences in inflammatory responses demonstrated in patients undergoing endovascular as opposed to classic surgical treatment of abdominal aortic aneurysms (AAAs). Methods: The clinical course of seven patients treated with an endoluminal procedure (AAA-E) and seven patients undergoing conventional surgery (AAA-C) were compared (all men; ages 52 to 80 years). Blood samples were taken pre-, intra-, and postoperatively for up to 7 days. Inflammatory responses were assessed from measurement of interleukins (IL)-1 β, IL-6, IL-8, and tumor necrosis factor (TNF-α); complement proteins C1q, C4, C5a, and terminal complement complexes, C5b-C9; and C-reactive proteins. Granulocyte and monocyte surface adhesion molecule expression was determined indirectly using a panel of monoclonal antibodies against CD11a, CD11b, CD11c, CD18, and L-selectin in donor white blood cells exposed to patient plasma. Results: In six of the AAA-E patients, blood pressure decreases were recorded during the introduction of the device. Elevated body temperature was sustained for 2 to 5 days postoperatively in the AAA-E group. IL-6 levels were significantly higher in AAA-C patients (p < 0.0005), while TNF-α release was recorded in the AAA-E group only. CD11b, CD11c, and CD18 molecules on both granulocytes and monocytes were significantly upregulated 60 minutes after the endovascular procedure compared to conventional surgery. Conclusions: Endovascular aortic aneurysm repair apparently induces a significant inflammatory response, mainly involving TNF-α release, which differs from open AAA repair. These inflammatory responses, which may be related to the observed intraprocedural blood pressure decreases, could be caused by cell activation arising from intra-aneurysmal device manipulation.
Collapse
Affiliation(s)
- L Norgren
- Department of Surgery, University Hospital, Lund, Sweden
| | | |
Collapse
|
17
|
Harris PL, Buth J, Mialhe C, Myhre HO, Norgren L. The Need for Clinical Trials of Endovascular Abdominal Aortic Aneurysm Stent-Graft Repair: The EUROSTAR Project. J Endovasc Ther 2016; 4:72-7; discussion 78-9. [PMID: 9034923 DOI: 10.1177/152660289700400113] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
EUROSTAR(EUROpean collaborators on Stent-graft Techniques for abdominal aortic Aneurysm Repair) was established for the purpose of combining and studying data on endovascular abdominal aortic aneurysm (AAA) repair. EUROSTAR is independent of any commercial interest and has as its ultimate goal an independent, scientifically reliable assessment of endovascular AAA grafting. A standardized case record form is used for data collection and transmission, and the database is maintained in a central registry office. A comprehensive set of clinical, imaging, technical, and laboratory data obtained at initial admission and follow-up are recorded; these data are analyzed periodically and reports generated on the collated experience. As a first priority, an observational study without controls was initiated in July 1996 to address the issues of procedural safety, device durability, and long-term effect upon the aneurysms. Several ancillary studies have been initiated, including a “Retrieval and Analysis Study” for the evaluation of explanted devices. While a randomized study does not seem feasible at present, this may be organized at the appropriate time when the devices and techniques become more standardized.
Collapse
Affiliation(s)
- P L Harris
- Vascular Surgery Unit, Royal Liverpool University Hospital, United Kingdom
| | | | | | | | | |
Collapse
|
18
|
Breddin HK, Browse NL, Smith PDC, Cornu-Thénard A, Dormandy JA, Franzeck UK, Fronek A, Hume M, Kuiper JP, Michel CC, Norgren L, Partsch H, Ruckley CV, Schmid-Schönbein GW, Schultz-Ehrenburg U, Scurr JH, Stricht JPVD, Vanscheidt W, Villavicencio JL, Widmer LK. Consensus Paper on Venous Leg Ulcers. Phlebology 2016. [DOI: 10.1177/026835559200700202] [Citation(s) in RCA: 57] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
19
|
Abstract
Objective: To study the effect of graduated compression on maternal and fetal haemodynamics. Design: Measurement of maternal and fetal heart rate and uterine artery flow velocity ( Vmax) in supine and standing positions with and without graduated compression hosiery (25 mmHg at the ankle). Setting: Department of Surgery, Lund University, S-22185 Lund, Sweden. Patients: Eighteen women in gestational week 32–38. Results: An increase in heart rate on standing was recorded for both mother and fetus. Graduated compression stockings decreased these changes. Cyclic heart rate changes were not frequent. Uterine artery flow velocity did not change during change of posture or after compression. Conclusion: The utero-vascular syndrome was not common in the patients studied. Graduated compression reduced the vascular response to standing, measured as an increase of heart frequency at standing.
Collapse
Affiliation(s)
- C. Austrell
- Department of Surgery, Lund University, Lund, Sweden
| | - L. Nilsson
- Department of Surgery, Lund University, Lund, Sweden
| | - L. Norgren
- Department of Surgery, Lund University, Lund, Sweden
| |
Collapse
|
20
|
Jungbeck C, Thulin I, Darenheim C, Norgren L. Graduated Compression Treatment in Patients with Chronic Venous Insufficiency: A Study Comparing Low and Medium Grade Compression Stockings. Phlebology 2016. [DOI: 10.1177/026835559701200405] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Objective: Patients with chronic venous insufficiency (CVI) benefit subjectively from treatment with graduated compression stockings. Usually, class II compression is used in patients with CVI grade II. The present study investigates possible differences between graduated compression of classes I and II. Design: Randomized study. Setting: Department of Vascular Surgery and Vascular Laboratory, University Hospital, Lund. Patients and Methods: Thirty-one patients, nine male and 22 female (59 legs), all with grade II CVI. Foot volumetry and a visual analogue scale (VAS) were used to assess symptoms. Patients were randomized to either class I or class II graduated compression, and the examinations were repeated after 8 weeks of treatment. Results: The VAS assessment showed that all patients benefited to the same extent and there were no differences between the two compression classes. An increase of the expelled volume with compression was recorded, to a significant degree with class I compression. Reflux values were not significantly influenced by either grade of compression. Conclusion: Class I graduated compression did not show any difference in subjective effect or objective parameters compared with Class II. Class I compression can be recommended instead of class II compression, especially in patients who find that the higher pressure on the leg causes discomfort.
Collapse
Affiliation(s)
- C. Jungbeck
- Department of Surgery, Lund University, Sweden
| | - I. Thulin
- Department of Surgery, Lund University, Sweden
| | | | - L. Norgren
- Department of Surgery, Lund University, Sweden
| |
Collapse
|
21
|
Abstract
Objective: To measure the abnormalities of venous function in patients with decompensated heart failure. Design: Single group study. Setting: Departments of Medicine and Surgery, Lund University Hospital, Lund, Sweden. Patient: Forty-seven patients with decompensated heart failure due to myocardial insufficiency. Interventions: Conventional medical treatment for decompensated heart failure. The application of graduated compression stockings randomly applied to one leg. Main outcome measures: Strain gauge plethysmography assessment of venous capacitance and maximum venous outflow. Results: Graduated compression stockings increased venous volume significantly, but did not influence maximum venous outflow. Conclusion: The principal effect of compression stockings is probably a direct effect upon the veins in the leg in patients with decompensated heart failure.
Collapse
Affiliation(s)
| | - L. Norgren
- Department of Surgery, Lund University, Lund, Sweden
| |
Collapse
|
22
|
Lagerstedt C, Olsson CG, Fagher B, Norgren L, Tengborn L. Recurrence and Late Sequelae after First-Time Deep Vein Thrombosis: Relationship to Initial Signs. Phlebology 2016. [DOI: 10.1177/026835559300800205] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Objective: To investigate the relation between initial symptoms and long-term sequelae in first-time deep venous thrombosis (DVT). Design: Follow-up study of patients 6 years after an episode of suspected symptomatic DVT. Setting: Vascular laboratory, University Hospital of Lund. Patients: 66 patients, 19 with femoral DVT, 20 with calf DVT and 27 with normal phlebograms at initial investigation. Main outcome measures: Symptoms and signs of chronic venous insufficiency (CVI), foot volumetry and measurement of plasminogen activator inhibitor 1 (PAI-1) activity. Initial clinical signs and results at phlebography were compared with findings at follow-up. Results: Of patients with DVT, 11 (28%) had been treated for a recurrent DVT during follow-up. No relation was found between initial signs of DVT and late signs of CVI. Patients with DVT had significantly more signs of CVI but symptoms did not differ between the groups. Mean levels of PAI-1 activity were similar in the three groups, and patients with recurrent DVT did not differ. Refilling flow was related to the clinical CVI-score, and expelled volume was inversely related to the extension of DVT at phlebography. Conclusion: The recurrence rate is high in first-time DVT, but symptoms are mostly mild as long as after 6 years. There is a poor correlation between symptoms of CVI and objective findings. The late development of CVI cannot be predicted from the clinical signs in the acute phase. Levels of PAI-1 do not correlate with the degree of CVI.
Collapse
Affiliation(s)
- C. Lagerstedt
- Department of Internal Medicine, University Hospital, Lund
| | - C.-G. Olsson
- Department of Internal Medicine, University Hospital, Lund
| | - B. Fagher
- Department of Internal Medicine, University Hospital, Lund
| | - L. Norgren
- Department of Surgery, University Hospital, Lund
| | - L. Tengborn
- Department of Coagulation Laboratory, Sahlgrenska Sjukhuset, Göteborg, Sweden
| |
Collapse
|
23
|
Abstract
Objectives: To evaluate venous function during pregnancy and to compare two levels of graduated compression. Design: Prospective, randomized study. Setting: Vascular Surgery and Vascular Laboratory, University Hospital. Patients: Fifty pregnant women using graduated compression with pantyhose stockings exerting either 25 or 13 mmHg ankle pressure. Eight pregnant women acting as controls. Interventions: Foot volumetry to determine venous function (venous emptying during exercise and reflux) close to week 20, week 33 and post-partum. Results: The expelled volume increased significantly when graduated compression stockings were used. Refilling flow did not change significantly. Few patients with reflux were found. Conclusion: Graduated compression stockings of pantyhose type are effective in increasing venous emptying during pregnancy. Stockings exerting an ankle pressure of 13 mmHg at the ankle level were as effective as those exerting 25 mmHg.
Collapse
Affiliation(s)
- C. Austrell
- Department of Surgery, Lund University, Lund, Sweden
| | - I. Thulin
- Department of Surgery, Lund University, Lund, Sweden
| | - L. Norgren
- Department of Surgery, Lund University, Lund, Sweden
| |
Collapse
|
24
|
Abstract
Objective: To evaluate the effect of compression hosiery during standing work. Design: An open study, comparing symptoms and plethysmographic findings before and after treatment. Setting: University hospital, vascular surgery. Subjects: Forty-eight female volunteers with a standing profession. Methods: Visual analogue scale to evaluate symptoms and foot volumetry to study venous function before and after 4 weeks use of compression hosiery (20–30 mmHg). Result: All scores for symptoms were significantly reduced after treatment. Only 21% of the study subjects had minor abnormalities on foot volumetry. The expelled volume was significantly higher after work at 4 weeks than at the first measurement at inclusion, while the refilling rate was significantly lower after work at 4 weeks than at the corresponding measurement at inclusion. Conclusion: Symptomatic improvement was recorded after compression treatment. Limited effects were seen with the objective measurement, although the most important factor, the refilling rate, diminished significantly during the treatment period. Compression treatment reduces lower limb symptoms following standing work.
Collapse
Affiliation(s)
- C. Jungbeck
- Department of Vascular Diseases, University Hospital MAS, Malmö, Sweden
| | - K. Peterson
- Department of Vascular Diseases, University Hospital MAS, Malmö, Sweden
| | - G. Danielsson
- Department of Vascular Diseases, University Hospital MAS, Malmö, Sweden
| | - L. Norgren
- Department of Vascular Diseases, University Hospital MAS, Malmö, Sweden
| |
Collapse
|
25
|
Norgren L. Commentary on 'Peripheral Arterial Disease Incidence and Associated Risk Factors in a Mediterranean Population Based Cohort. The REGICOR Study'. Eur J Vasc Endovasc Surg 2016; 51:706. [PMID: 26935966 DOI: 10.1016/j.ejvs.2016.01.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2016] [Accepted: 01/10/2016] [Indexed: 11/25/2022]
Affiliation(s)
- L Norgren
- Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
| |
Collapse
|
26
|
Larzon T, Roos H, Gruber G, Henrikson O, Magnuson A, Falkenberg M, Lönn L, Norgren L. A Randomized Controlled Trial of the Fascia Suture Technique Compared with a Suture-mediated Closure Device for Femoral Arterial Closure after Endovascular Aortic Repair. J Vasc Surg 2015. [DOI: 10.1016/j.jvs.2014.12.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
27
|
Larzon T, Roos H, Gruber G, Henrikson O, Magnuson A, Falkenberg M, Lönn L, Norgren L. Editor's Choice - A Randomized Controlled Trial of the Fascia Suture Technique Compared with a Suture-mediated Closure Device for Femoral Arterial Closure after Endovascular Aortic Repair. Eur J Vasc Endovasc Surg 2015; 49:166-73. [DOI: 10.1016/j.ejvs.2014.10.021] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2014] [Accepted: 10/03/2014] [Indexed: 12/17/2022]
|
28
|
Jonsson TB, Nilsson TK, Breimer LH, Schneede J, Arfvidsson B, Norgren L. Cloxacillin concentrations in serum, subcutaneous fat, and muscle in patients with chronic critical limb ischemia. Eur J Clin Pharmacol 2014; 70:957-63. [DOI: 10.1007/s00228-014-1695-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2014] [Accepted: 05/02/2014] [Indexed: 12/01/2022]
|
29
|
Norgren L, Hiatt WR, Jaff MR. Response to ‘Statement from the European Society of Vascular Surgery and the World Federation of Vascular Surgery Societies’ Inter-Society Consensus Document (TASC) III and International Standards for Vascular Care (ISVaC). Eur J Vasc Endovasc Surg 2014; 47:461. [PMID: 24851281 DOI: 10.1016/j.ejvs.2014.02.010] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
30
|
Hörer TM, Skoog P, Norgren L, Magnuson A, Berggren L, Jansson K, Larzon T. Intra-peritoneal microdialysis and intra-abdominal pressure after endovascular repair of ruptured aortic aneurysms. Eur J Vasc Endovasc Surg 2013; 45:596-606. [PMID: 23540804 DOI: 10.1016/j.ejvs.2013.03.002] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2012] [Accepted: 03/02/2013] [Indexed: 02/07/2023]
Abstract
OBJECTIVES This study aims to evaluate intra-peritoneal (ip) microdialysis after endovascular aortic repair (EVAR) of ruptured abdominal aortic aneurysm (rAAA) in patients developing intra-abdominal hypertension (IAH), requiring abdominal decompression. DESIGN Prospective study. MATERIAL AND METHODS A total of 16 patients with rAAA treated with an emergency EVAR were followed up hourly for intra-abdominal pressure (IAP), urine production and ip lactate, pyruvate, glycerol and glucose by microdialysis, analysed only at the end of the study. Abdominal decompression was performed on clinical criteria, and decompressed (D) and non-decompressed (ND) patients were compared. RESULTS The ip lactate/pyruvate (l/p) ratio was higher in the D group than in the ND group during the first five postoperative hours (mean 20 vs. 12), p = 0.005 and at 1 h prior to decompression compared to the fifth hour in the ND group (24 vs. 13), p = 0.016. Glycerol levels were higher in the D group during the first postoperative hours (mean 274.6 vs. 121.7 μM), p = 0.022. The IAP was higher only at 1 h prior to decompression in the D group compared to the ND group at the fifth hour (mean 19 vs. 14 mmHg). CONCLUSIONS Ip l/p ratio and glycerol levels are elevated immediately postoperatively in patients developing IAH leading to organ failure and subsequent abdominal decompression.
Collapse
Affiliation(s)
- T M Hörer
- Department of Cardio-Thoracic and Vascular Surgery, Örebro University Hospital and Örebro University, Örebro, Sweden.
| | | | | | | | | | | | | |
Collapse
|
31
|
Jonsson TB, Larzon T, Arfvidsson B, Tidefelt U, Axelsson CG, Jurstrand M, Norgren L. Adverse events during treatment of critical limb ischemia with autologous peripheral blood mononuclear cell implant. INT ANGIOL 2012; 31:77-84. [PMID: 22330628] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
AIM Trials have reported clinical improvement and reduced need for amputation in critical limb ischemia (CLI) patients receiving therapeutic angiogenesis with stem cells. Our objective was to test peripheral stem cell therapy efficacy and safety to gain experiences for further work. METHODS We included nine CLI patients (mean age 76.7 ±9.7). Stem cells were mobilized to the peripheral blood by administration of G-CSF (Filgrastim) for 4 days, and were collected on day five, when 30 mL of a stem cell suspension was injected into 40 points of the limb. The clinical efficacy was evaluated by assessing pain relief, wound healing and changes in ankle-brachial pressure index (ABI). Local metabolic and inflammatory changes were measured with microdialysis, growth factors and cytokine level determination. Patients were followed for 24 weeks. RESULTS Four patients experienced some degree of improvement with pain relief and/or improved wound healing and ABI increase. One patient was lost to follow up due to chronic psychiatric illness; one was amputated after two weeks. Two patients had a myocardial infarction (MI), one died. One patient died from a massive mesenteric thrombosis after two weeks and one died from heart failure at week 11. Improved patients showed variable effects in cytokine-, growth factor- and local metabolic response. CONCLUSION Even with some improvement in four patients, severe complications in four out of nine patients, and two in relation to the bone marrow stimulation, made us terminate the study prematurely. We conclude that with the increased risk and the reduced potential of the treatment, peripheral blood stem cell treatment in the older age group is less appropriate. Metabolic and inflammatory response may be of value to gain insight into mechanisms and possibly to evaluate effects of therapeutic angiogenesis.
Collapse
Affiliation(s)
- T B Jonsson
- Department of Surgery, University Hospital, Örebro, Sweden.
| | | | | | | | | | | | | |
Collapse
|
32
|
Van Belle E, Nikol S, Norgren L, Baumgartner I, Driver V, Hiatt W, Belch J. Insights on the Role of Diabetes and Geographic Variation in Patients with Criticial Limb Ischaemia. Eur J Vasc Endovasc Surg 2011; 42:365-73. [DOI: 10.1016/j.ejvs.2011.04.030] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2010] [Accepted: 04/26/2011] [Indexed: 10/18/2022]
|
33
|
El Marghani AM, Abuabaid HM, Hurtig-Wennlöf A, Sirsjö A, Norgren L, Kjellen P. High MAPK p38 activity and low level of IL-10 in intermittent claudication as opposed to stable angina. INT ANGIOL 2010; 29:331-337. [PMID: 20671651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
AIM The aim of the present pilot study was to relate the activity of MAPK p38 with the levels of pro- and anti-inflammatory cytokines in a small cohort of patients with either stable angina (N=5) or intermittent claudication (N=5) compared to healthy controls (N=10). METHODS The activity of MAPK p38 was determined in peripheral blood mononuclear cells, isolated from whole blood by western blot using phospho-specific anti-MAPK p38 antibodies. Cytokine levels of 11 pro- and anti-inflammatory cytokines were determined from the serum using flow cytometry. RESULTS We found a significant elevation of the MAPK p38 activity in the intermittent claudication group (P=0.0027) compared with the healthy control group whereas the stable angina group showed similar MAPK p38 activity as the healthy control group. The IL-10 level in serum found in the stable angina group was significantly higher compared with both the healthy control group (P=0.0116) and the intermittent claudication group (P=0.0317). CONCLUSION Our results imply that there is a casual relationship between increased levels of the anti-inflammatory cytokines IL-10 and IL-4 and the activity of the MAPK p38. Possibly has IL-10 a protective role that down-regulates the activity of MAPK p38 and thereby further inflammatory processes in stable angina patients.
Collapse
Affiliation(s)
- A M El Marghani
- School of Science and Technology, Orebro University, Orebro, Sweden
| | | | | | | | | | | |
Collapse
|
34
|
Belch JJF, Dormandy J, Biasi GM, Biasi BM, Cairols M, Diehm C, Eikelboom B, Golledge J, Jawien A, Lepäntalo M, Norgren L, Hiatt WR, Becquemin JP, Bergqvist D, Clement D, Baumgartner I, Minar E, Stonebridge P, Vermassen F, Matyas L, Leizorovicz A. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg 2010; 52:825-33, 833.e1-2. [PMID: 20678878 DOI: 10.1016/j.jvs.2010.04.027] [Citation(s) in RCA: 221] [Impact Index Per Article: 15.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2009] [Revised: 04/07/2010] [Accepted: 04/12/2010] [Indexed: 12/25/2022]
Abstract
OBJECTIVE Dual antiplatelet therapy with clopidogrel plus acetylsalicylic acid (ASA) is superior to ASA alone in patients with acute coronary syndromes and in those undergoing percutaneous coronary intervention. We sought to determine whether clopidogrel plus ASA conferred benefit on limb outcomes over ASA alone in patients undergoing below-knee bypass grafting. METHODS Patients undergoing unilateral, below-knee bypass graft for atherosclerotic peripheral arterial disease (PAD) were enrolled 2 to 4 days after surgery and were randomly assigned to clopidogrel 75 mg/day plus ASA 75 to 100 mg/day or placebo plus ASA 75 to 100 mg/day for 6 to 24 months. The primary efficacy endpoint was a composite of index-graft occlusion or revascularization, above-ankle amputation of the affected limb, or death. The primary safety endpoint was severe bleeding (Global Utilization of Streptokinase and Tissue plasminogen activator for Occluded coronary arteries [GUSTO] classification). RESULTS In the overall population, the primary endpoint occurred in 149 of 425 patients in the clopidogrel group vs 151 of 426 patients in the placebo (plus ASA) group (hazard ratio [HR], 0.98; 95% confidence interval [CI], 0.78-1.23). In a prespecified subgroup analysis, the primary endpoint was significantly reduced by clopidogrel in prosthetic graft patients (HR, 0.65; 95% CI, 0.45-0.95; P = .025) but not in venous graft patients (HR, 1.25; 95% CI, 0.94-1.67, not significant [NS]). A significant statistical interaction between treatment effect and graft type was observed (P(interaction) = .008). Although total bleeds were more frequent with clopidogrel, there was no significant difference between the rates of severe bleeding in the clopidogrel and placebo (plus ASA) groups (2.1% vs 1.2%). CONCLUSION The combination of clopidogrel plus ASA did not improve limb or systemic outcomes in the overall population of PAD patients requiring below-knee bypass grafting. Subgroup analysis suggests that clopidogrel plus ASA confers benefit in patients receiving prosthetic grafts without significantly increasing major bleeding risk.
Collapse
Affiliation(s)
- Jill J F Belch
- Institute of Cardiovascular Research, Ninewells Hospital, Dundee, UK.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Jansson K, Jansson M, Andersson M, Magnuson A, Ungerstedt U, Norgren L. Normal values and differences between intraperitoneal and subcutaneous microdialysis in patients after non‐complicated gastrointestinal surgery. Scandinavian Journal of Clinical and Laboratory Investigation 2009; 65:273-81. [PMID: 16076682 DOI: 10.1080/00365510510013802] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
OBJECTIVE Visceral ischemia is an early event in the development of shock and organ failure. Microdialysis has been presented as a promising method for detection of visceral hypoxia and ischemia. The aim of this study was to investigate differences in the metabolic response measured by microdialysis between intraperitoneal and subcutaneous locations and to estimate normal values of lactate/pyruvate ratio, glucose and glycerol. MATERIAL AND METHODS Intraperitoneal and subcutaneous metabolic responses were compared regarding lacate/pyruvate ratio, glucose and glycerol, during 45 postoperative hours in 33 patients undergoing various non-complicated elective major gastrointestinal surgery. RESULTS Intraperitoneal lactate/pyruvate ratio started around 15 and decreased over time, while subcutaneous levels were stable around 9. Glucose levels were higher intraperitoneally and increased rapidly during the first 9 h to 8.6 mM, while the subcutaneous levels increased during 21 h to 7.5 mM. Intraperitoneal glycerol levels were stable around 100 microM, while subcutaneous values started around 230 microM and then increased. CONCLUSIONS In a non-complicated postoperative course the lactate/pyruvate ratio and glucose levels are higher intraperitoneally, suggesting a higher postoperative intraperitoneal metabolism. Glycerol levels are higher and increase subcutaneously, suggesting increased postoperative energy demand, particularly in the visceral organs, as being responsible for the lipolysis seen in the subcutaneous tissue.
Collapse
Affiliation(s)
- K Jansson
- Department of Surgery, Orebro University Hospital, Sweden.
| | | | | | | | | | | |
Collapse
|
36
|
Kierkegaard A, Norgren L, Olsson CG, Castenfors J, Persson G, Persson S. Incidence of deep vein thrombosis in bedridden non-surgical patients. Acta Med Scand 2009; 222:409-14. [PMID: 3425393 DOI: 10.1111/j.0954-6820.1987.tb10957.x] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
In order to detect deep vein thrombosis (DVT), 101 patients with acute medical or infectious disorders were examined with the 125I-fibrinogen uptake test. All patients were bedridden on admission and were scanned daily from the second to the eighth day. Thirteen patients developed a positive fibrinogen uptake test. Thus, if a positive test is interpreted as DVT, the incidence of DVT was 13% in our bedridden patients. Of the patients admitted because of heart disease or pneumonia 20% had DVT, but only 4% of those admitted with other diagnoses. Other clinical "risk factors" studied, could not identify patients who developed DVT.
Collapse
Affiliation(s)
- A Kierkegaard
- Department of Internal Medicine, University of Lund, Sweden
| | | | | | | | | | | |
Collapse
|
37
|
Lindholm L, Ejlertsson G, Forsberg L, Norgren L. Low prevalence of abdominal aortic aneurysm in hypertensive patients. A population-based study. Acta Med Scand 2009; 218:305-10. [PMID: 3907287 DOI: 10.1111/j.0954-6820.1985.tb06129.x] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
The prevalence of abdominal aortic aneurysms (AAA) was estimated by ultrasonography in hypertensives in the age group 50-70 years in geographically defined population. Only one case of AAA was found among 245 patients. This rather unexpected result implies a probability of less than 5% that the true prevalence of AAA is as high as 2% in hypertensives. Our population-based study indicates a lower prevalence than earlier studies based on necropsies and is an example of research cooperation between primary health care and specialized hospital care.
Collapse
|
38
|
Liapis CD, Bell PRF, Mikhailidis D, Sivenius J, Nicolaides A, Fernandes e Fernandes J, Biasi G, Norgren L. ESVS Guidelines. Invasive Treatment for Carotid Stenosis: Indications, Techniques. Eur J Vasc Endovasc Surg 2009; 37:1-19. [PMID: 19286127 DOI: 10.1016/j.ejvs.2008.11.006] [Citation(s) in RCA: 412] [Impact Index Per Article: 27.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2008] [Accepted: 11/07/2008] [Indexed: 12/18/2022]
Affiliation(s)
- C D Liapis
- Department of Vascular Surgery, Athens University Medical School, Attikon University Hospital, Athens, Greece.
| | | | | | | | | | | | | | | |
Collapse
|
39
|
Dormandy J, Betteridge D, Schernthaner G, Pirags V, Norgren L. Impact of peripheral arterial disease in patients with diabetes—Results from PROactive (PROactive 11). Atherosclerosis 2009; 202:272-81. [DOI: 10.1016/j.atherosclerosis.2008.03.002] [Citation(s) in RCA: 47] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/12/2007] [Revised: 02/28/2008] [Accepted: 03/03/2008] [Indexed: 10/22/2022]
|
40
|
Novo S, Balbarini A, Belch JJ, Bonura F, Clement DL, Diamantopoulos E, Fareed J, Norgren L, Poredos P, Rotzocil K. The metabolic syndrome: definition, diagnosis and management. INT ANGIOL 2008; 27:220-231. [PMID: 18506125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
|
41
|
Abstract
The present knowledge on endovascular repair of ruptured abdominal aortic aneurysms (rAAA) prevents firm conclusions when to use this method in comparison to open repair. This review article briefly summarizes results from case series, and discusses how to achieve reliable information despite the absence of randomized controlled trials. At present a careful conclusion might be that dedicated centers with an adequate organization and reasonably high volume of abdominal aortic aneurysm (AAA) should use detailed registry protocols to achieve experience and data to create an as reliable basis as possible for future recommendations.
Collapse
Affiliation(s)
- L. Norgren
- Department of Surgery, University Hospital, Örebro, Sweden
| | - T. Larzon
- Department of Surgery, University Hospital, Örebro, Sweden
| |
Collapse
|
42
|
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, Rutherford RB. Inter-society consensus for the management of peripheral arterial disease. INT ANGIOL 2007; 26:81-157. [PMID: 17489079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/15/2023]
|
43
|
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45 Suppl S:S5-67. [PMID: 17223489 DOI: 10.1016/j.jvs.2006.12.037] [Citation(s) in RCA: 3853] [Impact Index Per Article: 226.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- L Norgren
- Department of Surgery, University Hospital, Orebro, Sweden
| | | | | | | | | | | |
Collapse
|
44
|
|
45
|
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J, Clement D, Creager M, Jaff M, Mohler E, Rutherford RB, Sheehan P, Sillesen H, Rosenfield K. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2006; 33 Suppl 1:S1-75. [PMID: 17140820 DOI: 10.1016/j.ejvs.2006.09.024] [Citation(s) in RCA: 1795] [Impact Index Per Article: 99.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2006] [Accepted: 09/15/2006] [Indexed: 01/19/2023]
Affiliation(s)
- L Norgren
- Department of Surgery, University Hospital, Orebro, Sweden.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Danielsson P, Truedsson L, Norgren L. Systemic white blood and endothelial cell response after revascularization of critical limb ischemia is only influenced in case of ischemic ulcers. INT ANGIOL 2006; 25:310-5. [PMID: 16878082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/11/2023]
Abstract
AIM The aim of this study was to study the inflammatory response to open revascularization of an ischemic leg in terms of activation of white blood cells (WBC), platelets and endothelial cells. DESIGN prospective study. METHODS Venous samples from 21 patients suffering critical limb ischemia (CLI) were drawn before, and 4 weeks after (20 patients) revascularization. Total WBC, differentiated WBC, and platelets were counted. Expression of CD11b/CD18 on granulocytes and monocytes and CD41 on platelets was measured by flow cytometry. Soluble endothelial markers (sICAM-1, sVCAM-1, sE-selectin and sP-selectin) were analysed with ELISA. RESULTS WBC and granulocyte count decreased in the subgroup of patients with ulcer and gangrene but no change in activation of WBC was recorded. The endothelial marker sICAM-1 decreased while VCAM-1 increased following surgery, most evident in the subgroup with ulcers and gangrene. CONCLUSIONS This study shows that revascularization of CLI does not significantly influence the inflammatory response in patients with rest pain only, but a limited response of down regulation was found in the ulcer/gangrene patients probably as an effect of healing ulcers.
Collapse
Affiliation(s)
- P Danielsson
- Department of Vascular Diseases, University Hospital MAS, Malmö, Sweden.
| | | | | |
Collapse
|
47
|
Matyas L, Schulte KL, Dormandy JA, Norgren L, Sowade O, Grötzbach G, Palmer-Kazen U, Rubanyi GM, Wahlberg E. Arteriogenic gene therapy in patients with unreconstructable critical limb ischemia: a randomized, placebo-controlled clinical trial of adenovirus 5-delivered fibroblast growth factor-4. Hum Gene Ther 2006; 16:1202-11. [PMID: 16218781 DOI: 10.1089/hum.2005.16.1202] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
The objectives of this study were to assess the safety and potential clinical efficacy of adenovirus-delivered fibroblast growth factor-4 (Ad5FGF-4) by intramuscular injection into patients with critical limb ischemia (CLI). This study was a double-blind, randomized, placebo-controlled study with escalating dose groups of 2.87 x 10(8) to 2.87 x 10(10) viral particles. Thirteen patients with CLI were randomized to receive active drug (n = 10) or placebo (n = 3). Safety evaluations and efficacy parameters (ankle-brachial index, digital subtraction angiograms, magnetic resonance imaging, and scintigraphy) were performed at baseline and for 12 weeks after treatment. Injections of Ad5FGF-4 were generally well tolerated and considered safe. Transfection efficacy at these concentrations may have been limited or local. The small sample size did not allow any firm conclusions regarding clinical efficacy but a trend toward more and slightly larger blood vessels was observed in the angiograms. It is concluded that intramuscular injection of Ad5FGF-4 into CLI patients seemed safe, but transfection efficacy was limited at the assessed doses. Conclusions regarding clinical efficacy are impossible to draw from this small patient cohort.
Collapse
Affiliation(s)
- L Matyas
- Borsod County Hospital, H-3501 Miskolc, Hungary
| | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Matyas L, Schulte KL, Dormandy J, Norgren L, Sowade O, Grotzbach G, Palmer-Kazen U, Rubanyi G, Wahlberg E. Arteriogenic Gene Therapy in Patients with Unreconstructable Critical Limb Ischemia: A Randomized, Placebo-Controlled Clinical Trial of Adenovirus 5-Delivered Fibroblast Growth Factor-4. Hum Gene Ther 2005. [DOI: 10.1089/hum.2005.16.ft-127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
49
|
Larzon T, Gruber G, Friberg O, Geijer H, Norgren L. Experiences of Intentional Carotid Stenting in Endovascular Repair of Aortic Arch Aneurysms—Two Case Reports. Eur J Vasc Endovasc Surg 2005; 30:147-51. [PMID: 15996601 DOI: 10.1016/j.ejvs.2005.02.049] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2004] [Accepted: 02/24/2005] [Indexed: 11/23/2022]
Abstract
Endovascular repair of thoracic aneurysms has emerged as an attractive alternative especially in patients at high risk. However, the left common carotid artery limits the use of stent-grafts in aneurysms located in the aortic arch or close to the left subclavian artery. We report two cases with aneurysms in the distal arch and proximal descending aorta, where we have used a carotid stent in juxtaposition to an aortic stent-graft, to gain a longer proximal neck in the aortic arch in an attempt not to rely only on a by-pass graft feeding the left carotid artery.
Collapse
Affiliation(s)
- T Larzon
- Department of Surgery, Orebro University Hospital, Orebro, Sweden.
| | | | | | | | | |
Collapse
|
50
|
Norgren L, Jansson K. Intraperitoneal and intraluminal microdialysis in the detection of experimental regional intestinal ischaemia (Br J Surg 2004; 91: 855-861). Br J Surg 2004; 91:1653. [PMID: 15547887 DOI: 10.1002/bjs.4892] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|